Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Human Vaccines
|
August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
Daniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases
|
January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
Daniel M Musher, Susan B Manof, Charlie Liss, et al.
Cancer
|
May 13, 2008
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity
Amar Safdar, Gilhen H Rodriguez, Adriana M Rueda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 28, 2009
A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection
Hoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2007
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A Mandell, Richard G Wunderink, Antonio Anzueto, et al.
Annals of the American Thoracic Society
|
August 20, 2015
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia
Luis Molinos, Rafael Zalacain, Rosario Menéndez, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 2, 2019
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P Metlay, Grant W Waterer, Ann C Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 28, 2025
Practicing With Intent: How to Teach an Old Dogma New Tricks
Matthew C Phillips, Kusha Davar, Sarah Freling, et al.
Pharmacology Research & Perspectives
|
July 15, 2022
A practical treatment for COVID-19 and the next pandemic
Jahar Bhattacharya, Robert Booy, Arturo Casadevall, et al.
Health Affairs Scholar
|
February 7, 2025
Sustainable solutions to the continuous threat of antimicrobial resistance
Brad Spellberg, David N Gilbert, Michael Baym, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Human Vaccines
|
August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
Daniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases
|
January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
Daniel M Musher, Susan B Manof, Charlie Liss, et al.
Cancer
|
May 13, 2008
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity
Amar Safdar, Gilhen H Rodriguez, Adriana M Rueda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 28, 2009
A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection
Hoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2007
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A Mandell, Richard G Wunderink, Antonio Anzueto, et al.
Annals of the American Thoracic Society
|
August 20, 2015
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia
Luis Molinos, Rafael Zalacain, Rosario Menéndez, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 2, 2019
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P Metlay, Grant W Waterer, Ann C Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 28, 2025
Practicing With Intent: How to Teach an Old Dogma New Tricks
Matthew C Phillips, Kusha Davar, Sarah Freling, et al.
Pharmacology Research & Perspectives
|
July 15, 2022
A practical treatment for COVID-19 and the next pandemic
Jahar Bhattacharya, Robert Booy, Arturo Casadevall, et al.
Health Affairs Scholar
|
February 7, 2025
Sustainable solutions to the continuous threat of antimicrobial resistance
Brad Spellberg, David N Gilbert, Michael Baym, et al.
Page
of 19